Alamar Biosciences
- Market cap
- 1.93B
- P/E (TTM)i
- -38.78
- P/Bi
- 6.16
- EPSi
- -0.54
- Div yieldi
- 0.00%
- 52W posi
- 43%
Anonymous reader poll. Unscientific, not investment advice.
Alamar Biosciences shares were changing hands at 27.77, down 13.92% on the day. The company carries a market value of roughly 1.93B, the #2657 most valuable US-listed company we track. Wall Street's 4-analyst consensus lands on Buy, with a price target averaging 33.00 (+19% from here). The shares sit 43% of the way up their 52-week range of 18.85 to 39.61.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 year.
- Recent price momentum is +10.1% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 3.1% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 32.26
- Open
- 31.65
- Day range
- 27.76 - 32.02
- Avg price
- 29.24
- Volume
- 1.15M
- Turnover
- 33.57M
- Turnover ratei
- 8.88%
- Volume ratioi
- 1.59
- Amplitudei
- 13.21%
- 52-week rangei
- 18.85 - 39.61
Valuation
- P/Ei
- -51.43
- P/E (TTM)i
- -38.78
- P/Bi
- 6.16
- EPSi
- -0.54
- Book value / shi
- 4.51
- Net profit
- -37.47M
- Net assets
- 312.89M
Share structure
- Market cap
- 1.93B
- Float capi
- 359.27M
- Shares out
- 69.39M
- Float sharesi
- 12.94M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2026-04-17
29.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+656.82K net over the window
Short interest
- Shares short
- 2.12M
- % of floati
- 3.06%
- Days to coveri
- 7.95
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Alamar Biosciences (ALMR)?
Alamar Biosciences last traded at 27.77. The quote on this page refreshes every few seconds while US markets are open.
What is Alamar Biosciences's market cap?
About 1.93B.
What is the P/E ratio of Alamar Biosciences?
The trailing twelve-month P/E is -38.78. The Valuation tab shows it against the stock's own five-year range.
Does Alamar Biosciences pay a dividend?
Alamar Biosciences does not currently pay a regular dividend.
Is Alamar Biosciences a buy according to analysts?
The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 33.00, which implies 18.8% upside from the current price. This is not investment advice.
What is Alamar Biosciences's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Alamar Biosciences a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-10-08 08:17:12 · For reference only, not investment advice and not tailored to your situation.